• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Therapeutic alternatives in metastatic neuroendocrine tumors.

作者信息

Miller C A, Ellison E C

机构信息

Department of Surgery, Ohio State University Medical Center, Columbus, Ohio, USA.

出版信息

Surg Oncol Clin N Am. 1998 Oct;7(4):863-79.

PMID:9735138
Abstract

In the treatment of neuroendocrine tumors that cannot be resected for cure two goals must be addressed: (1) the control of symptoms related to hormonal hypersecretion and (2) the prolongation of survival by destruction of tumor of the limitation of its growth. Clinical approaches, medical and surgical, have been developed in recent years to meet these goals. Surgical options in the face of metastatic disease include resection of hepatic metastases, cryoablation, and liver transplantation. Medical therapy includes treatment of symptomatic hypersecretory states and systemic chemotherapeutic and immunomodulatory regimes. Hepatic artery chemoembolization has also been used successfully in the treatment of hepatic metastases of neuroendocrine tumors.

摘要

相似文献

1
Therapeutic alternatives in metastatic neuroendocrine tumors.
Surg Oncol Clin N Am. 1998 Oct;7(4):863-79.
2
Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.肝转移神经内分泌癌的治疗:消融技术的作用
Cardiovasc Intervent Radiol. 2005 Jul-Aug;28(4):409-21. doi: 10.1007/s00270-004-4082-6.
3
A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors.
J Am Coll Surg. 1995 Feb;180(2):184-7.
4
Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.尽管使用了奥曲肽治疗,但对于伴有进行性肝转移的神经内分泌癌,采用肝动脉化疗灌注联合化疗栓塞治疗。
Surgery. 2008 Dec;144(6):885-93; discussion 893-4. doi: 10.1016/j.surg.2008.08.037.
5
Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.神经内分泌恶性肿瘤肝转移的治疗:十年经验
J R Coll Surg Edinb. 2002 Apr;47(2):495-9.
6
Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?全身和局部非手术治疗——转移性神经内分泌癌的最佳策略是什么?
Surg Oncol Clin N Am. 2007 Jul;16(3):639-51, x. doi: 10.1016/j.soc.2007.04.019.
7
[Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].[胃肠胰系统神经内分泌肿瘤的肝转移——治疗策略]
Zentralbl Chir. 2009 Sep;134(5):410-7. doi: 10.1055/s-0029-1224607. Epub 2009 Sep 15.
8
Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.肝减瘤术联合一种新型长效生长抑素类似物:治疗转移至肝脏的难治性神经内分泌肿瘤的范例
Surgery. 2001 Dec;130(6):954-62. doi: 10.1067/msy.2001.118388.
9
Surgical management of liver metastases from gastrointestinal endocrine tumors.胃肠道内分泌肿瘤肝转移的外科治疗
Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):274-82. doi: 10.1016/j.gcb.2010.02.001. Epub 2010 Mar 26.
10
Cryoablation for liver tumors - is there clinical utility?肝脏肿瘤的冷冻消融——有临床应用价值吗?
MedGenMed. 2003 Nov 7;5(4):19.

引用本文的文献

1
Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment.双靶点细胞外囊泡促进神经内分泌癌联合治疗
Pharmaceutics. 2020 Nov 11;12(11):1079. doi: 10.3390/pharmaceutics12111079.
2
Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.基于神经内分泌肿瘤靶向性上转换纳米粒子的胶束用于近红外控制的联合化疗和光动力疗法以及荧光成像
Adv Funct Mater. 2017 Feb 23;27(8). doi: 10.1002/adfm.201604671. Epub 2017 Jan 17.
3
Synergistic effect of pasireotide and teriflunomide in carcinoids in vitro.
体外研究表明,帕瑞肽与特立氟胺对类癌具有协同作用。
Neuroendocrinology. 2013;97(2):183-92. doi: 10.1159/000341810. Epub 2012 Sep 4.
4
Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.抑制磷脂酰肌醇3-激酶/蛋白激酶B信号传导可抑制胃肠道类癌肿瘤中的肿瘤细胞增殖和神经内分泌标志物表达。
Ann Surg Oncol. 2009 Oct;16(10):2936-42. doi: 10.1245/s10434-009-0591-5. Epub 2009 Jul 9.
5
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.胃肠道神经内分泌肿瘤治疗与缓解的新靶点。
Curr Opin Investig Drugs. 2008 Jun;9(6):576-82.
6
Actual role of radiofrequency ablation of liver metastases.肝转移瘤射频消融的实际作用。
Eur Radiol. 2007 Aug;17(8):2062-70. doi: 10.1007/s00330-007-0587-0. Epub 2007 Feb 15.
7
Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.转移性神经内分泌肿瘤的肝移植:一例病例报告及文献综述
World J Gastroenterol. 2005 Dec 28;11(48):7676-83. doi: 10.3748/wjg.v11.i48.7676.
8
Survival and functional quality of life after resection for hepatic carcinoid metastasis.肝类癌转移切除术后的生存率和生活功能质量
J Gastrointest Surg. 2004 Sep-Oct;8(6):653-9. doi: 10.1016/j.gassur.2004.04.003.
9
[Radiofrequency ablation of liver metastases].
Radiologe. 2004 Apr;44(4):347-57. doi: 10.1007/s00117-004-1033-9.